Breast Cancer

Mar 27, 2025

Alcon Gains CE Mark for Clareon Vivity IOL in Europe; MicroPort MedBot’s Toumai SP Robot Wins NMPA Approval; Abbott Launches Intravascular Lithotripsy Trial; BD Advances GalaFLEX LITE™ Clinical Trial; GE HealthCare Unveils AI-Powered Invenia ABUS Premium; Okami Medical Introduces SENDERO® MAX Catheter

Dec 09, 2024

How CDK4/6 Inhibitors Are Changing the Cancer Treatment Paradigm?

Nov 04, 2024

CDK7 Inhibitors: A Promising Class in Cancer Therapeutics

Aug 14, 2024

Breast Cancer Insights: Identifying Symptoms and Protecting Your Health

Aug 13, 2024

Roche’s HER2-Positive Breast Cancer Treatment Franchise

Aug 13, 2024

7 Most Common Myths About Breast Cancer Demystified

Aug 08, 2024

Novel Insights Into New Therapies for HR+/HER2- Breast Cancer

Aug 08, 2024

HR+/HER2- Breast Cancer: Unveiling the Worldwide Advances and Strategies

Aug 08, 2024

How HR+/ HER2-Breast Cancer Emerging Drugs Will Transform The Market?

Aug 08, 2024

The Evolving Landscape of ER+ Breast Cancer Treatments

Newsletter/Whitepaper